Patents Represented by Attorney, Agent or Law Firm Pillsbury Madison & Sutro LLP Intellectual Property
Group
-
Patent number: 6258547Abstract: cDNAs encoding mammalian AMP protein kinases, corresponding polypeptides and recombinant proteins together with antibodies thereto. Their uses including the study of gene expression and the characteristics of other proteins.Type: GrantFiled: March 6, 1996Date of Patent: July 10, 2001Assignee: Zeneca LimitedInventors: Rajinder Kumar Beri, David Carling, Robert Anthony Forder
-
Patent number: 6240517Abstract: An IC card processing system includes a telephone set for generating random number data, an IC card for processing value data, a secret key, and random number data by an authenticator generation function to generate authentication code, a switching unit for processing value data, a secret key, and random number data by an authenticator generation function to generate authentication code, and a comparator for comparing the authentication code generated by the IC card with the authentication code generated by the switching unit to authenticate the IC card.Type: GrantFiled: January 30, 1998Date of Patent: May 29, 2001Assignee: Kabushiki Kaisha ToshibaInventor: Mitsuru Nishioka
-
Patent number: 6191020Abstract: A conductive interconnection for an integrate circuit between a protected node and a protecting node and its method are disclosed. The conductive interconnection comprises a stacking connector, a routing connector and a top conductive line. The stacking connector is formed to connect the protected node, which is constructed by at least one inner conductive line and at least one conductive plug, alternately. The inner conductive line has a length lower than a threshold value constrained by antenna effect. Moreover, the routing connector, extending toward the stacking connector, is formed to connect the protecting node. The top conductive line is used to connect the stacking connector and the routing connector. Accordingly, the protected node is disconnected from the protecting node prior to the formation of the top conductive line.Type: GrantFiled: May 21, 1998Date of Patent: February 20, 2001Assignee: Taiwan Semiconductor Manufacturing Company, Ltd.Inventors: Jing-Meng Liu, Shao-Yu Wang
-
Patent number: 6191841Abstract: A peripheral region of an array substrate is coated with a sealing agent in a manner to surround a display region, followed by arranging an opposite substrate to face the array substrate with a predetermined gap defined therebetween. Then, the sealing agent is heated for the curing while pressurizing the array substrate and the opposite substrate so as to seal these two substrates. After the sealing step, a liquid crystal composition is injected into the clearance between the array substrate and the opposite substrate through a liquid crystal injecting port formed in the sealing agent. The sealing agent should maintain a viscosity of at least 110 poises during the curing step of the sealing agent. The viscosity of the sealing agent, which is provided by a resin composition, is controlled by, for example, using a main component resin having a high molecular weight, a solvent having a low boiling point, and a curing agent that is liquid at room temperature.Type: GrantFiled: November 30, 1999Date of Patent: February 20, 2001Assignee: Kabushiki Kaisha ToshibaInventors: Hiroshi Ootaguro, Kazuyoshi Okano
-
Patent number: 6187835Abstract: Radiation-curable inner and outer primary optical fiber coatings are disclosed having both fast cure speed and reduced rates of yellowing. The compositions comprise particular photoinitiators and UV absorbers which are used in amounts to provide the combination of properties. The UV absorber can have ethylenic unsaturation. Outer primary coatings can be formulated to screen inner primary coatings and have fast cure speed.Type: GrantFiled: June 18, 1998Date of Patent: February 13, 2001Assignee: DSM N.V.Inventors: David M. Szum, Chander P. Chawla, Timothy E. Bishop
-
Patent number: 6176477Abstract: The liquid-sealing type vibration isolating apparatus of the present invention includes a coupler attached to a vibrating body, a holder, an insulator for absorbing and isolating vibration from the vibrating body at a position between the coupler and the holder, and a vibration isolating mechanism directly following the insulator and including liquid chambers sealing an incompressible fluid. This vibration isolating mechanism has a main chamber sealing a liquid, having a part of wall thereof formed by the insulator, an auxiliary chamber communicating with the main chamber via an orifice, and an equilibrium chamber provided in a portion of the main chamber via a diaphragm and having a varying volume in the chamber. The vibration isolating apparatus further includes switching means for introducing a negative pressure and the atmospheric pressure continuously or in synchronization with vibration of the vibrating body, and control means for controlling this switching operation.Type: GrantFiled: March 3, 1998Date of Patent: January 23, 2001Assignee: Toyoda Gosei Co. LTd.Inventors: Shigeki Takeo, Takashi Maeno, Masanao Gotou, Hiroshi Yokoi, Takeshi Naito, Tomoyuki Sawatari, Hisayoshi Kato, Osamu Nakagaki
-
Patent number: 6169131Abstract: The invention relates to a plastic sheeting which is suitable, in particular, for application in the construction industry. It is obtained by employing polyetherester block copolymers and has good humidity-regulating properties and water impermeability. Flame retardancy in accordance with DIN 4102 B2 is obtained by employing melamine, melamine compounds or melamine condensates in the polyetherester composition for the sheeting.Type: GrantFiled: June 22, 1998Date of Patent: January 2, 2001Assignee: DSM N.V.Inventors: Henricus J. J. Goertz, Richerdes J. M. Hulskotte, Reinoldus J. M. Borggreve
-
Patent number: 6165315Abstract: A reactor for the synthesis of urea from ammonia and carbon dioxide at elevated temperature and pressure is provided with perforated reactor trays in which at least a pair of spaced part perforated reactor trays each have at least one opening at least a distance closer towards the periphery than the center, such as on or near the edge of a perforated reactor tray, and each of such pair perforated reactor trays is provided with a tube with a height of 50-500 mm located on and depending from an underside, e.g. bottom side in a column reactor, of each of such pair perforated reactor tray. The tubes extend to no more than 1/3 of the distance between two adjacent reactor trays.Type: GrantFiled: May 3, 1999Date of Patent: December 26, 2000Assignee: DSM N.V.Inventors: Kees Jonckers, Hendrik F. Perree
-
Patent number: 6156257Abstract: A polyurethane material is injected into a mold cavity having a reduced pressure to form e.g. the surface portion of a polyurethane covering for a steering wheel. A polyurethane material for forming a substantial inner portion thereof and free of any coloring matter is, then, injected into the cavity. Then, a polyurethane material containing coloring matter is injected into the cavity to form the remaining inner portion of the covering.Type: GrantFiled: December 10, 1996Date of Patent: December 5, 2000Assignee: Toyoda Gosei Co., LtdInventors: Katsumi Tachi, Toshihiko Asaya
-
Patent number: 6146717Abstract: The invention comprises a process for impregnating components with polymerizable impregnants which are liquid at room temperature or can be liquefied by heating and are cured by combined use of heat and high-energy radiation, wherein the components are impregnated at ambient temperature or in a preheated state and, after impregnation, are heated in the impregnant until partial gelation occurs, are treated with high-energy radiation before full curing and are then fully cured by thermal means.Type: GrantFiled: June 23, 1999Date of Patent: November 14, 2000Assignee: Schenectady International, Inc.Inventors: Klaus-Wilhelm Lienert, Rainer Blum, Gunter Hegemann, Manfred Eichhorst
-
Patent number: 6146314Abstract: A pedal-type exerciser includes a first drive assembly having a first horizontal axle mounted rotatably on a rear end portion of a base, first and second drive wheels mounted securely and coaxially on the first horizontal axle, and a pair of first crank arms mounted securely on opposite ends of the first horizontal axle. A second drive assembly has a second horizontal axle mounted rotatably on a front end portion of the base, a third drive wheel mounted securely on the second horizontal axle, a transmission chain trained on the second drive wheel and the third drive wheel, and a pair of second crank arms mounted securely on opposite ends of the second horizontal axle. Each of a pair of elongate pedal members has a front portion with a distal end of a corresponding second crank arm mounted pivotally and slidably therealong, and a rear portion mounted pivotally on a distal end of a corresponding first crank arm.Type: GrantFiled: May 15, 1998Date of Patent: November 14, 2000Assignee: Stamina Products, Inc.Inventor: Sunny Lee
-
Patent number: 6143775Abstract: The invention provides a pharmaceutical composition comprising a particular physical form of N-[4-[5-(cyclopentyloxy-carbonyl)amino-1-methylindol-3-yl-methyl]-3-methox ybenzoyl]-2-methyl-benzenesulphonamide and polyvinylpyrrolidone. It also provides methods for preparing this physical form, and another physical form of N-[4-[5-(cyclopentyloxycarbonyl)amino-1-methylindol-3-yl-methyl]-3-methoxy benzoyl]-2-methylbenzenesulphonamide useful in the preparation of the first mentioned physical form. The compositions are useful in the treatment of diseases in which leukotrienes are implicated, for example asthma.Type: GrantFiled: November 23, 1999Date of Patent: November 7, 2000Assignee: Zeneca LimitedInventors: James Joseph Holohan, Ieuan John Edwards
-
Patent number: 6093718Abstract: This invention concerns heterocyclic derivatives which are useful in inhibiting oxido-squalene cyclase, processes for their preparation and pharmaceutical compositions containing them. The present invention is also concerned with heterocyclic derivatives capable of inhibiting cholesterol biosynthesis and hence in lowering cholesterol levels in blood plasma. The present invention also relates to methods of using such heterocyclic derivatives in diseases and medical conditions such as hypercholesterolemia and atherosclerosis.Type: GrantFiled: February 12, 1999Date of Patent: July 25, 2000Assignee: Zeneca LimitedInventors: David Waterson, Elaine Sophie Elizabeth Stokes, George Robert Brown, Nicholas John Newcombe
-
Patent number: 6079622Abstract: A non-contact information storage medium for receiving power from a card reader/writer via an antenna, using the power for driving its internal circuit, and simultaneously transmitting data as a transmission wave to the outside thereof. The output current of a rectifier circuit is interrupted by a switching circuit incorporated in a modulation circuit in accordance with the transmission wave. In the period of interruption, the output voltage of the rectifier circuit is limited by a voltage limiting circuit incorporated in the modulation circuit to a value not more than the breakdown voltage of elements which constitute the circuit. The loss of power during data transmission is extremely small, and hence the circuit can be constituted by elements of a usual breakdown voltage.Type: GrantFiled: October 24, 1997Date of Patent: June 27, 2000Assignee: Kabushiki Kaisha ToshibaInventor: Yuichi Goto
-
Patent number: 6071921Abstract: The invention relates to quinazoline derivatives of the formula: ##STR1## [wherein: Y.sup.1 represents --O--, --S--, --CH.sub.2 --, --SO--, --SO.sub.2 --, --NR.sup.5 CO--, --CONR.sup.6 --, --SO.sub.2 NR.sup.7 --, --NR.sup.8 SO.sub.2 -- or --NR.sup.9 -- (wherein R.sup.5, R.sup.6, R.sup.7, R.sup.8 and R.sup.9 each independently represents hydrogen, alkyl or alkoxyalkyl);R.sup.1 represents hydrogen, hydroxy, halogeno, nitro, trifluoromethyl, cyano, alkyl, alkoxy, alkylthio, amino or alkylamino.R.sup.2 represents hydrogen, hydroxy, halogeno, alkyl, alkoxy, trifluoromethyl, cyano, amino or nitro;m is an integer from 1 to 5;R.sup.3 represents hydroxy, halogeno, alky, alkoxy, alkanoyloxy, trifluoromethyl, cyano, amino or nitro;R.sup.Type: GrantFiled: December 2, 1998Date of Patent: June 6, 2000Assignees: Zeneca Limited, Zeneca Pharma S.A.Inventors: Jean-Jacques Marcel Lohmann, Laurent Francois Andre Hennequin, Andrew Peter Thomas
-
Patent number: 6054282Abstract: A method for the detection of a compound which modulates binding of a ligand to a biological receptor, which method comprises contacting the ligand, biological receptor and test compound at a locus on a solid phase matrix, the matrix allowing movement of fluids therein by capillary action, under conditions which permit binding of the ligand to the biological receptor and partition of any unbound ligand on the solid phase matrix, and detecting any modulation of binding by the test compound by reference to any such partition.Type: GrantFiled: February 14, 1996Date of Patent: April 25, 2000Assignee: Zeneca LimitedInventor: Andrew John Garman
-
Patent number: 6051666Abstract: A method for polymerizing at least one olefin by contacting at least one olefin with a polymerization catalyst and an organometallic compound containing a metal from group 1, 2, 12 or 13 of the Periodic System of Elements under effective polymerization conditions. The polymerization catalyst is obtained by contacting metallic magnesium with an aromatic halide, RX, under conditions effective to obtain a first reaction product and solid residual products. The first reaction product is then separated from the solid residual products. A silane compound containing an alkoxy or aryloxy group is added to the first reaction product between -20.degree. C. to 20.degree. C. to obtain a precipitate which is purified to obtain a second reaction product. Subsequently, the second reaction product is contacted with a halogenized titanium compound, such as titanium tetrachloride, to obtain a further reaction product. The polymerization catalyst is obtained by purifying the further reaction product.Type: GrantFiled: October 9, 1997Date of Patent: April 18, 2000Assignee: DSM N.V.Inventors: Vladimir A. Zakharov, Gennadii D. Bukatov, Sergei A. Sergeev
-
Patent number: 6045732Abstract: A multi-layer molded article having a skin material layer made of a vinyl chloride resin, a propylene resin core, and an adhesive layer present between the skin material layer and the core, in which the adhesive layer includes (A) a layer having (a) a sublayer containing a polyester resin and an epoxy group-containing ethylene copolymer, which is bonded to the skin material of the vinyl chloride resin, and (b) a sublayer containing at least one copolymer selected from an ethylene copolymer and an epoxy group-containing copolymer, which is bonded to said propylene resin core, or (B) a layer obtained from an ethylene resin composition containing a polybasic carboxylic acid and an epoxy-group containing copolymer (c) which contains ethylene units, unsaturated carboxylic acid glycidyl ester units or unsaturated glycidyl ether units and an ethylenically unsaturated ester units other than the unsaturated carboxylic acid glycidyl ester units.Type: GrantFiled: October 22, 1997Date of Patent: April 4, 2000Assignee: Sumitomo Chemical Company, LimitedInventors: Yoshihiro Nakatsuji, Hiroyuki Sugimoto, Kohsuke Ohtani, Toshio Igarashi, Satoru Funakoshi, Harunori Fujita
-
Patent number: 6034175Abstract: This invention relates to novel salts composed of a cation derived from a peptide containing at least one basic group and an anion derived from a carboxy-terminated polyester, processes for the manufacture of such salts, and the use of such salts in the manufacture of extended release pharmaceutical compositions. The salts of the invention possess a variety of properties which are useful in the formulation of extended release pharmaceutical compositions, whether the salts are in pure form or are in admixture with either an excess of the peptide in its free, unbound form or an excess of the free polyester.Type: GrantFiled: January 22, 1999Date of Patent: March 7, 2000Assignee: Zeneca LimitedInventor: Francis Gowland Hutchinson
-
Patent number: RE37314Abstract: The compounds of the present invention inhibit the HMG-CoA reductase, and subsequently suppress the biosynthesis of cholesterol. And they are useful in the treatment of hypercholesterolemia, hyperlipoproteinemia, and atherosclerosis.Type: GrantFiled: August 27, 1998Date of Patent: August 7, 2001Assignee: Shionogi Seiyaku Kabushiki KaishaInventors: Kentaro Hirai, Teruyuki Ishiba, Haruo Koike, Masamichi Watanabe